Envestnet Asset Management
DNA icon

Envestnet Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Envestnet Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,166
Closed -$163K – 4247
2024
Q2 		$163K Sell
12,166
-9,937
-45% -$296K ﹤0.01% 3982
2024
Q1 		$1.03M Buy
22,103
+4,325
+24% +$224K ﹤0.01% 3014
2023
Q4 		$1.2M Buy
17,778
+8,857
+99% +$542K ﹤0.01% 2811
2023
Q3 		$646K Buy
8,921
+3,265
+58% +$261K ﹤0.01% 3107
2023
Q2 		$421K Buy
5,656
+2,862
+102% +$169K ﹤0.01% 3299
2023
Q1 		$149K Sell
2,794
-553
-17% -$35K ﹤0.01% 3727
2022
Q4 		$226K Buy
3,347
+26
+0.8% +$2.39K ﹤0.01% 3611
2022
Q3 		$414K Buy
3,321
+1,243
+60% +$148K ﹤0.01% 3131
2022
Q2 		$198K Buy
2,078
+767
+59% +$93.5K ﹤0.01% 3609
2022
Q1 		$211K Buy
+1,311
New +$255K ﹤0.01% 3657

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return